Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells

Journal of Immunological Methods

Volumn 313, Issue 1-2, 2006, Pages 48-60

  Montag, David T ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Flow cytometry; PBMC; Phosphorylation; Signaling; STAT

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CELL SURFACE PROTEIN; CYTOKINE; EPITOPE; METHANOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN;

ANTIGEN DETECTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LABORATORY TEST; MEDICAL ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION;

ACETONE; ANTIGENS, CD; ANTIGENS, SURFACE; CELL MEMBRANE PERMEABILITY; CYTOKINES; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; METHANOL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SAPONINS; STAT TRANSCRIPTION FACTORS; STAT1 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE;

EID: 33745137317     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.03.014     Document Type: Article

References (28)

1. Aringer M., Karonitsch T., Steiner C.W., Feierl E., Steiner G., and Smolen J.S. Stat1 and phosphorylated Stat1 are increased in lymphocytes and monocytes of patients with systemic lupus erythematosus. Arthritis Res. Ther. 7S (2005) 133
2. Bromberg J., and Darnell Jr. J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19 (2000) 2468
3. Campana D., Neale G.A., Coustan-Smith E., and Pui C.H. Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience. Leukemia 15 (2001) 278
4. Desplat V., Lagarde V., Belloc F., Chollet C., Leguay T., Pasquet J.M., Praloran V., and Mahon F.X. Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells. Cytometry A 62 (2004) 35
5. Dong C., Davis R.J., and Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 20 (2002) 55
6. Donnenberg V.S., O'Connell P.J., Logar A.J., Zeevi A., Thomson A.W., and Donnenberg A.D. Rare-event analysis of circulating human dendritic cell subsets and their presumptive mouse counterparts. Transplantation 72 (2001) 1946
7. Gouilleux-Gruart V., Gouilleux F., Desaint C., Claisse J.F., Capiod J.C., Delobel J., Weber-Nordt R., Dusanter-Fourt I., Dreyfus F., Groner B., and Prin L. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87 (1996) 1692
8. Halary F., Pitard V., Dlubek D., Krzysiek R., de la Salle H., Merville P., Dromer C., Emilie D., Moreau J.F., and Dechanet-Merville J. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J. Exp. Med. 201 (2005) 1567
9. Hoffmann T.K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J.T., and Whiteside T.L. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin. Cancer Res. 8 (2002) 2553
10. Kim S.C., Hahn J.S., Min Y.H., Yoo N.C., Ko Y.W., and Lee W.J. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93 (1999) 3893
11. Krutzik P.O., and Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 55 (2003) 61
12. Lesinski G.B., Kondadasula S.V., Crespin T., Shen L., Kendra K., Walker M., and Carson III W.E. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy. J. Natl. Cancer Inst. 96 (2004) 1331
13. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev., Mol. Cell Biol. 3 (2002) 651
14. Lotze M.T., and DeMarco R.A. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4 (2003) 1405
15. Lotze M.T., Wang E., Marincola F.M., Hanna N., Bugelski P.J., Burns C.A., Coukos G., Damle N., Godfrey T.E., Howell W.M., Panelli M.C., Perricone M.A., Petricoin E.F., Sauter G., Scheibenbogen C., Shivers S.C., Taylor D.L., Weinstein J.N., and Whiteside T.L. Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health. J. Immunother. 28 (2005) 79
16. Martin-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22 (2000) 637
17. Mascher B., Schlenke P., and Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods 223 (1999) 115
18. Mora L.B., Buettner R., Seigne J., Diaz J., Ahmad N., Garcia R., Bowman T., Falcone R., Fairclough R., Cantor A., Muro-Cacho C., Livingston S., Karras J., Pow-Sang J., and Jove R. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 62 (2002) 6659
19. Mudter J., Weigmann B., Bartsch B., Kiesslich R., Strand D., Galle P.R., Lehr H.A., Schmidt J., and Neurath M.F. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100 (2005) 64
20. Oka H., Chatani Y., Hoshino R., Ogawa O., Kakehi Y., Terachi T., Okada Y., Kawaichi M., Kohno M., and Yoshida O. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55 (1995) 4182
21. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell. Signal. 12 (2000) 1
22. Sivaraman V.S., Wang H., Nuovo G.J., and Malbon C.C. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99 (1997) 1478
23. Skinnider B.F., Elia A.J., Gascoyne R.D., Patterson B., Trumper L., Kapp U., and Mak T.W. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99 (2002) 618
24. Smithgall T.E., Briggs S.D., Schreiner S., Lerner E.C., Cheng H., and Wilson M.B. Control of myeloid differentiation and survival by Stats. Oncogene 19 (2000) 2612
25. Towatari M., Iida H., Tanimoto M., Iwata H., Hamaguchi M., and Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11 (1997) 479
26. Uzel G., Frucht D.M., Fleisher T.A., and Holland S.M. Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100 (2001) 270
27. Watson C.J., and Miller W.R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer 71 (1995) 840
28. Whiteside T.L. Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?. Cancer Immunol. Immunother. 53 (2004) 865